Navigation Links
The Analysis of Polycyclic Aromatic Hydrocarbons (PAHs) by LC/MS/MS Using ,,, an Atmospheric Pressure Photoionization Source

The atmospheric pressure photoionization source, PhotoSpray ion source (Robb, Covey and Bruins1) uses photons to ionize large quantities of a dopant molecule added along with the vaporized mobile phase. Analyte molecules are efficiently ionized through secondary reactions initiated by the charged dopant. This new technique was used to develop an analytical method for polycyclic aromatic hydrocarbons (PAHs), comparing the difference under reverse phase and normal phase chromatographic conditions. A total of 16 PAHs were analysed including the determination of unknown quantities in atmospheric samples from both rural and urban areas.

Introduction

Polycyclic aromatic hydrocarbons (PAHs) are a group of over 100 different chemicals, typically formed during incomplete combustion, which are present in a variety of environmental matrices. Airborne PAHs, usually found in aerosol particles, are implicated in heterogeneous atmospheric processing and as important indicators of gas-phase atmospheric processes. Certain carcinogenic PAHs may be carried by ultrafine particles in ambient air into the lungs, and are often the targets of rigorous environmental monitoring. Currently, environmental PAHs are most commonly analysed by HPLC or GC/EI-MS; techniques which require long, high-resolution separations, and complicated MS methods. Atmospheric pressure photoionization is a new technique that uses the energy of photons to generate ions from the vaporized eluent of an LC. This study compares the analysis of PAHs by LC/MS/MS using both reverse phase and normal phase chromatographic conditions.

Materials and methods

A 20 ppm stock standard solution containing 16 common PAHs (see Figure 1). Under optimized LC/MS/MS conditions for both reversed phase and normal phase chromatographic
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. A Positive Selection Assay for Mutation Analysis in Big Blue Animals
2. Epitope-Tagging Vectors for Functional Analysis in Yeast
3. Map and Link Human Genetic Disorders with SSLP Analysis
4. CastAway Precast Gels for Rapid Automated DNA Sequence Analysis
5. Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf cMaster RTplusPCR System
6. Structural Analysis of Glycosylated Peptides in Complex Mixtures with Ion Trap MSn
7. Use of Transcriptor Reverse Transcriptase in Microarray Analysis
8. Increased Sensitivity in Microarray Analysis
9. Gene-Expression Analysis of TP, DPD, and TS Using the LightCycler mRNA Quantification KitsPLUS
10. Agilent 2100 Bioanalyzer Automated Analysis System
11. Analysis of Microarray Data
Post Your Comments:
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
(Date:5/21/2013)... New York, NY (PRWEB) May 21, 2013 ... years. And according to My Cleaning Products, many turn to ... However, because of the health and environmental risks those solutions ... bugs with Bed Bug Bully instead. , According ... on bed bugs as they used to be. It shared ...
(Date:5/21/2013)... May 21, 2013 Inflamax scientists ... the ITN to design the study, which will ... key clinical models used in the study of ... Nasal Allergen Challenge (NAC) models. Although both the ... publications, to date no direct comparison between the ...
(Date:5/21/2013)... SoundConnect is pleased to announce the release ... in Canada. Lync is the next generation of ... and organizations to collaborate and communicate much more easily ... the United States. With the progressive rollout of Lync ... Canada, SoundConnect now offers a complete Microsoft Lync solution ...
Breaking Biology Technology:MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3
... 23, 2010 Martek Biosciences, a company that launched ... University of Maryland, entered an agreement on December 21 ... NV for $1.1 billion, the companies jointly announced. ... is the second company sold for more than $1 ...
... Stanford University in the USA has an X-FEL (X-ray Free ... provides images of ,molecules in action, using a kilometer-long electron ... an alternative that can do many of the same things. ... half a million euro. That,s why the researchers have jokingly ...
... Md., Dec. 22, 2010 Novavax, Inc. (Nasdaq: ... Massachusetts Medical School, led by Dr. Trudy Morrison, published ... Virology, a report indicating that a novel virus-like particle ... mice from a live virus challenge.  This vaccine candidate ...
Cached Biology Technology:Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years 2Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years 3Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years 4Eindhoven University builds affordable alternative to mega-laser X-FEL 2Eindhoven University builds affordable alternative to mega-laser X-FEL 3NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate 2NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate 3NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate 4
(Date:5/19/2013)... Davis have engineered a strain of photosynthetic cyanobacteria to ... their findings today at the 113th General Meeting of ... we used synthetic biology approaches to probe and rewire ... for growth) cyanobacterial metabolism for the ability to grow ... on the study. He is part of Shota ...
(Date:5/18/2013)... 2013) Research presented at Digestive Disease Week ... through diet and lifestyle. , Individuals suffering ... muscle strength, fatigue and poor quality of life. ... in remission. A randomized, double blind, placebo-controlled study ... supplementation corresponded to significant relief of these symptoms. ...
(Date:5/17/2013)... provide the white noise of the South, but the night ... Southern air hangs heavy from the humidity and the sounds ... 140 species of frogs, toads and salamanders, is the center ... and swamps are the auditorium for their symphonic choruses, the ... Initiative, or ARMI, have front-row seats. , Amphibians, ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... clinical practice guideline, "Tonsillectomy in Children" will be published ... Surgery (watch for a new cover and publisher ... provides evidence-based recommendations on the pre-, intra-, and postoperative ... years under consideration for tonsillectomy. Additionally, this guideline is ...
... CORVALLIS, Ore. Members of the engineering faculty ... of radiation detection and measurement device that will be ... making the process faster, more accurate and less expensive. ... type of radiation spectrometer, and the first production of ...
... result in long waiting times for seriously ill patients. ... for the next available treatment. In this edition of ... 2010; 107[50]: 892𔃆), Michael Christ and his coauthors ... of emergency patients. Triage provides reliable methods that ...
Cached Biology News:Tonsillectomy in children 2New technology to speed cleanup of nuclear contaminated sites 2